RADIODYNAMIC AND CONTACT RADIATION THERAPY OF INOCULATED TUMOR IN AN IN VIVO EXPERIMENT
Journal: Cardiometry
Year: 2022

In recent years, interest in the use of such physical factors as magnetic fields, ultrasound, and hyperthermia to activate Photosensibilizers (PS) has increased in experimental oncology. One of the promising scientific areas is radiodynamic therapy (RDT), a new method of therapy based on the combined use of PS and ionizing radiation [1]. The first PS with the radiosensitizing properties proven in the in vitro/in vivo experiments were 5-aminolevulinic acid, Hematoporphyrin, and Photofrin II [2, 3